This small drug maker is taking on Allergan and Restasis

This small drug maker is taking on Allergan and Restasis

STAT Plus: This small Canadian drug maker is taking on Allergan and its best-selling eye drop medicine

By ADAM FEUERSTEIN

ADOBE

Allergan is appealing to the Supreme Court in an effort to stall generic competition to its drug. But the company faces a threat on a different front.

READ MORE